Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
NCT05894655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6527
Last updated 2025-11-04
Summary
Throughout the Coronavirus disease (COVID-19) pandemic, rates of COVID-19 have been persistently high in San Diego County's central and southern communities near the United States/Mexico border. These regions predominantly house Latino residents, the ethnic minority community most impacted by COVID-19 in San Diego. In the Phase I project, University of California, San Diego (UCSD) partnered with San Ysidro Health (SYH) and the Global Action Research Center, to co-create and demonstrate the impact of a COVID-19 testing program in San Ysidro, one of the most impacted areas from COVID-19 in San Diego County. To date, the project tested \>10,000 community members (92% Latino) and received requests to scale-out the testing program to additional primary care clinic sites.
In this Phase III project, Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences (CO-CREATE-Ex) will extend work with the Phase I community and clinical partners to refine, specify, implement, and evaluate an implementation strategy bundle that optimizes COVID-19 testing, expanding beyond current polymerase chain reaction (PCR) testing to FDA-authorized COVID-19 rapid antigen testing.
Conditions
- COVID-19
- COVID-19 Pandemic
Interventions
- BEHAVIORAL
-
COVID-19 walk-up, on-site testing strategy
This strategy is a no-appointment, walk-up point-of-care PCR and rapid testing strategy for clinic patients and community members. It will be offered 5 days/week for 7 hours during the first 3 months of the trial at Clinic 1. The intensity will decrease over the trial ending with 1 SYH Medical Assistant overseeing the testing protocol. Bilingual research staff will be trained to oversee onsite testing.
- BEHAVIORAL
-
Community Health Worker (CHW) leading testing navigation and general preventive care reminders
This strategy provides health counseling about when COVID-19 testing is recommended, which test to use, testing instructions, and how to interpret results. Community Health Workers (CHW) will also offer general preventive health care reminders such as flu shots, blood pressure checks, and A1c screenings. This strategy will be available full-time during the first 3 months of roll-out at each clinic and after 3 months, the CHW will be available as needed. Trained bilingual CHW will be supervised by a SYH employee.
- BEHAVIORAL
-
No-cost self-testing kit vending machines
This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime. The vending machines will be available 24 hours/day, 7 days a week.
Sponsors & Collaborators
-
San Ysidro Health Center
collaborator OTHER -
University of California, San Diego
lead OTHER
Principal Investigators
-
Louise Laurent, MD/PhD · University of California, San Diego
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-28
- Primary Completion
- 2025-03-31
- Completion
- 2025-10-08
Countries
- United States
Study Locations
More Related Trials
-
COVID-19 Contact Study by Antigen Detection Test
NCT04745533 ·Status: WITHDRAWN
-
COVID-19 Close Contact Self-Testing Study
NCT04847479 ·Status: COMPLETED ·Phase: NA
-
COVID Breath Test - Ancon
NCT04760639 ·Status: COMPLETED
-
Protecting Our Community: COVID-19 Testing
NCT04866303 ·Status: COMPLETED ·Phase: NA
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic
NCT04581083 ·Status: COMPLETED
-
COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)
NCT04367402 ·Status: UNKNOWN
-
Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention
NCT04081051 ·Status: COMPLETED ·Phase: NA
-
Symptom-Based Markers for COVID-19 Transmission
NCT04665245 ·Status: COMPLETED
-
Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study
NCT04894760 ·Status: COMPLETED
-
Assesment of the Metabolomic Signature in COVID-19 Patients
NCT04497272 ·Status: COMPLETED ·Phase: NA
-
CICERO- A Care Home Study of COVID-19
NCT04453553 ·Status: TERMINATED ·Phase: NA
-
Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19
NCT04607941 ·Status: COMPLETED
-
Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.
NCT05094674 ·Status: UNKNOWN ·Phase: NA
-
Prospective COVID-19 Cohort Study, Dominican Republic
NCT04898738 ·Status: COMPLETED ·Phase: NA
-
Serologic Testing of Household Contacts of Confirmed Cases of COVID-19
NCT04393142 ·Status: COMPLETED
-
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
NCT05621993 ·Status: UNKNOWN
-
Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments
NCT05638932 ·Status: COMPLETED
-
Health Professional Exposure Assessment to Covid-19
NCT04429724 ·Status: COMPLETED ·Phase: NA
-
C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting
NCT01918579 ·Status: COMPLETED ·Phase: NA
-
Preparedness Through Respiratory Virus Epidemiology and Community Engagement
NCT07147517 ·Status: RECRUITING
-
SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
NCT04497610 ·Status: WITHDRAWN
-
A Retrospective Study of COVID-19 Treatments
NCT04949230 ·Status: COMPLETED
-
Validation of Prognostic Clinical Risk Scores in Predicting Outcome for Patients With COVID-19 at Initial Triage
NCT05582382 ·Status: UNKNOWN
-
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373 ·Status: UNKNOWN